Colexion (CLXN), a licenced celebrity NFT market, has raised $5 million in funding from top venture capitalists

Colexion, which tokenizes the content of Bollywood and Tollywood stars, is going to trade the game in licensed NFTs

  • Colexion (CLXN) completes strategic funding with $5 million raised
  • First superstar NFT museum to go live

Colexion, a novel market for non-fungible tokens that addresses the buying and selling of NFTs authorized by using pinnacle TV, movie and sports stars, shares the important points of its current funding round.

Colexion (CLXN) completes strategic funding with $5 million raised
According to the press launch shared with Bitcoinsupports, Colexion (CLXN), an India-based marketplace for non-fungible tokens, has correctly closed its funding round.

A complete of $5,000,000 was raised through a take hold of of high-profile challenge funds. Polygon, Jump Trading, HyperEdge Capital, C² Ventures, GSR, Oracles Investment Group (OIG), Gains Associate, ZBS Capital, ICO Pantera, Titan Ventures, Good Games Lab and Maven Capital backed Colexion in its fundraising efforts.

Also, the protocol yielded contributions from top-tier angel buyers such as lan Howard of Brevan Howard and other blockchain investing veterans.

Following a successful two-phase funding campaign, Colexion (CLXN) is going to release its core native utility asset, CLXN, to mainstream launchpads Redkite, Prostarter, Scaleswap and Firestarter.

First celeb NFT museum to go live
Shortly after the initial decentralized trade providing (IDO), CLXN token will be listed on Tier 1 centralized and decentralized exchanges to strengthen its liquidity ecosystem.

Colexion is centered on bringing licensed NFTs to digital collectible markets. Colexion’s NFTs are authorized by Bollywood, Tollywood, TV stars and pinnacle athletes.

To promote this idea, Colexion (CLXN) is going to organize its NFT museum. On the upcoming immersive platform, legendary celebrities will depict their existence journeys to Web3 enthusiasts.

 

Disclaimer: These are the writer’s opinions and should not be considered investment advice. Readers should do their own research.

Leave a Comment

Your email address will not be published. Required fields are marked *

Facebook
Twitter
Telegram

Recent Posts

Follow Us